LIFECELL CORP. FDA Inspection Record

FEI 1000306051 · Inspections, Form 483s, warning letters and import refusals

LIFECELL CORP. is an FDA-registered facility (FEI 1000306051) located in BRANCHBURG, NJ, US. RegDataLab tracks 12 FDA inspections and 3 compliance actions at this facility.

What FDA found at this site

Latest inspection
May 21, 2024: No Action Indicated (NAI)
Inspections on record
12 (1 OAI, 2 VAI, 9 NAI)
Last OAI inspection
Nov 12, 2010
Warning letters
3 listed by FDA for this FEI, latest Jun 1, 2015
Recalls as the recalling firm
8, latest Dec 2, 2019

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Showing the 10 most recent of 12 inspections. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
May 21, 2024No Action Indicated (NAI)No citations listed
Feb 20, 2020No Action Indicated (NAI)No citations listed
Jun 14, 2019Voluntary Action Indicated (VAI)Procedures not adequately established or maintained (21 CFR 820.40)
Lack of or inadequate procedures (21 CFR 820.100(a))
Management review - Lack of or inadequate procedures (21 CFR 820.20(c))
Lack of or inadequate process validation (21 CFR 820.75(a))
Sep 27, 2017No Action Indicated (NAI)No citations listed
Aug 25, 2017No Action Indicated (NAI)Procedures not adequately established or maintained (21 CFR 820.40)
Lack of or inadequate procedures - Acceptance activities (21 CFR 820.80(a))
Lack of or inadequate procedures (21 CFR 820.100(a))
Documented evaluation (21 CFR 820.50(a)(1))
and 1 more
Jun 21, 2016No Action Indicated (NAI)No citations listed
May 14, 2015No Action Indicated (NAI)No citations listed
Sep 16, 2013No Action Indicated (NAI)No citations listed
Feb 1, 2013Voluntary Action Indicated (VAI)Sponsors' general responsibilities (21 CFR 812.40)
Aug 15, 2011No Action Indicated (NAI)No citations listed

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Dec 2, 2019Class IIB-0478-2020Skin - ALLODERM SELECT" Regenerative Tissue Matrix (RTM), Ready To Use product (RH205476…
Human bone allografts associated with a failure to prevent distribution of allografts that do not meet release criteria designed to prevent…
Aug 8, 2017Class IIZ-0823-2018REVOLVE ADVANCED ADIPOSE SYSTEM, for aspiration, harvesting, filtering, and transferring…
Presence of bacterial endotoxins levels above the acceptable limit
May 2, 2008Class IIIB-1138-08AlloDerm Regerative Tissue Matrix, 2x4 cm, .33-76 mm; AlloDerm GBR; 2x2 cm, .46-86 mm…
Skin allografts, recovered from a donor who was improperly assessed for hemodilution, were distributed.
Oct 17, 2007Class IIIB-0928-08Cryopreserved Allograft Skin, Non-Meshed and Cryopreserved Allograft Skin, Meshed and 9 more products
Human tissues from donors, tested using diagnostic test kits rather than FDA licensed or cleared screening tests for hepatitis B surface…
Oct 9, 2007Class IB-0909-08AlloDerm Regenerative Tissue Matrix Oral Plastic Surgery 1x2cm, .89-1.65 (mm) and 1x4cm… and 5 more products
A reactive (confirmed positive) test result for Hepatitis B Surface Antigen was obtained on a re-test sample from lot B16375,
Jul 21, 2006Class IIB-0128-7Acellular Dermal Matrix Grafts AlloDerm, Repliform and GraftJacket (91 tissue…
Human tissues, collected from a donor who had not been properly evaluated fro hemo-dilution, were distributed.
Jan 30, 2006Class IIB-1197-6Skin Tissue, AlloDerm/Repliform Regenerative Tissue Matrix.
Skin Tissue, that was subsequently found to test repeatedly reactive for antibodies to Hepatitis B Core Total (igM/IgG) by a different…
Sep 30, 2005Class IB-0276-6Acellular Dermal Matrix Skin Tissue
Human Tissues, procured from donors without adequate donor eligibility determinations, were distributed.

FDA record score

4 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

12 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAIJun 14, 20196 x 0.251.5
Class II recall B-0478-2020, this FEI as the recalling firmDec 2, 20194 x 0.251
Class II recall Z-0823-2018, this FEI as the recalling firmAug 8, 20174 x 0.251
Warning letter on FDA's dashboard, which does not show close-outsJun 1, 201510 years or older, so it adds no points0
Inspection classified VAIFeb 1, 201310 years or older, so it adds no points0
Warning letter on FDA's dashboard, which does not show close-outsMay 6, 201110 years or older, so it adds no points0
Inspection classified OAINov 12, 201010 years or older, so it adds no points0
Warning letter on FDA's dashboard, which does not show close-outsOct 10, 200810 years or older, so it adds no points0
Class I recall B-0909-08, this FEI as the recalling firmOct 9, 200710 years or older, so it adds no points0
Class II recall B-0128-7, this FEI as the recalling firmJul 21, 200610 years or older, so it adds no points0
Class II recall B-1197-6, this FEI as the recalling firmJan 30, 200610 years or older, so it adds no points0
Class I recall B-0276-6, this FEI as the recalling firmSep 30, 200510 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 16, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 16, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 16, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 16, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing LIFECELL CORP. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check LIFECELL CORP. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
LifeCell Corporation
Location
BRANCHBURG, NJ (US)
Source
device

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.